Protease inhibitor monotherapy: darunavir/ritonavir less effective than three-drug therapy
Do emtricitabine and lamivudine have similar virological efficacy when used in first-line HIV therapy?
Longer time to virological failure and less drug resistance seen in people taking Atripla than in people taking separate drugs
Switching from first-line ART with suppressed viral load linked to treatment failure
Dolutegravir demonstrates good efficacy despite resistance
